Vanguard Group’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.1M | Sell |
25,076,472
-2,701,306
| -10% | -$4.65M | ﹤0.01% | 2198 |
|
|
2025
Q1 | $92.5M | Buy |
27,777,778
+243,438
| +0.9% | +$811K | ﹤0.01% | 1830 |
|
|
2024
Q4 | $204M | Buy |
27,534,340
+220,373
| +0.8% | +$1.63M | ﹤0.01% | 1527 |
|
|
2024
Q3 | $256M | Buy |
27,313,967
+1,363,323
| +5% | +$12.8M | ﹤0.01% | 1407 |
|
|
2024
Q2 | $208M | Buy |
25,950,644
+1,035,344
| +4% | +$8.3M | ﹤0.01% | 1471 |
|
|
2024
Q1 | $369M | Buy |
24,915,300
+2,102,480
| +9% | +$31.2M | 0.01% | 1160 |
|
|
2023
Q4 | $185M | Buy |
22,812,820
+669,350
| +3% | +$5.44M | ﹤0.01% | 1547 |
|
|
2023
Q3 | $101M | Buy |
22,143,470
+1,748,082
| +9% | +$7.95M | ﹤0.01% | 1808 |
|
|
2023
Q2 | $144M | Buy |
20,395,388
+6,855,259
| +51% | +$48.3M | ﹤0.01% | 1652 |
|
|
2023
Q1 | $82.7M | Sell |
13,540,129
-922,953
| -6% | -$5.64M | ﹤0.01% | 1910 |
|
|
2022
Q4 | $92.4M | Buy |
14,463,082
+209,328
| +1% | +$1.34M | ﹤0.01% | 1843 |
|
|
2022
Q3 | $137M | Buy |
14,253,754
+890,727
| +7% | +$8.53M | ﹤0.01% | 1612 |
|
|
2022
Q2 | $148M | Buy |
13,363,027
+1,021,374
| +8% | +$11.3M | ﹤0.01% | 1603 |
|
|
2022
Q1 | $205M | Buy |
12,341,653
+143,866
| +1% | +$2.4M | ﹤0.01% | 1546 |
|
|
2021
Q4 | $233M | Buy |
12,197,787
+268,798
| +2% | +$5.13M | 0.01% | 1505 |
|
|
2021
Q3 | $294M | Sell |
11,928,989
-307,422
| -3% | -$7.58M | 0.01% | 1339 |
|
|
2021
Q2 | $318M | Buy |
12,236,411
+182,924
| +2% | +$4.76M | 0.01% | 1306 |
|
|
2021
Q1 | $382M | Buy |
12,053,487
+188,105
| +2% | +$5.96M | 0.01% | 1128 |
|
|
2020
Q4 | $551M | Buy |
11,865,382
+86,855
| +0.7% | +$4.03M | 0.02% | 837 |
|
|
2020
Q3 | $388M | Sell |
11,778,527
-449,943
| -4% | -$14.8M | 0.01% | 886 |
|
|
2020
Q2 | $336M | Buy |
12,228,470
+1,099,259
| +10% | +$30.2M | 0.01% | 956 |
|
|
2020
Q1 | $333M | Buy |
11,129,211
+276,082
| +3% | +$8.26M | 0.01% | 855 |
|
|
2019
Q4 | $300M | Buy |
10,853,129
+324,949
| +3% | +$8.99M | 0.01% | 1124 |
|
|
2019
Q3 | $192M | Buy |
10,528,180
+2,036,339
| +24% | +$37.1M | 0.01% | 1356 |
|
|
2019
Q2 | $208M | Buy |
8,491,841
+2,688,963
| +46% | +$65.9M | 0.01% | 1331 |
|
|
2019
Q1 | $55.2M | Buy |
5,802,878
+23,809
| +0.4% | +$226K | ﹤0.01% | 2037 |
|
|
2018
Q4 | $51.1M | Buy |
5,779,069
+1,730,287
| +43% | +$15.3M | ﹤0.01% | 2014 |
|
|
2018
Q3 | $45.6M | Buy |
4,048,782
+302,649
| +8% | +$3.4M | ﹤0.01% | 2188 |
|
|
2018
Q2 | $48M | Buy |
3,746,133
+470,277
| +14% | +$6.02M | ﹤0.01% | 2155 |
|
|
2018
Q1 | $55.4M | Buy |
3,275,856
+523,633
| +19% | +$8.85M | ﹤0.01% | 2022 |
|
|
2017
Q4 | $22M | Buy |
2,752,223
+245,384
| +10% | +$1.96M | ﹤0.01% | 2450 |
|
|
2017
Q3 | $19.4M | Buy |
2,506,839
+314,615
| +14% | +$2.44M | ﹤0.01% | 2501 |
|
|
2017
Q2 | $16.1M | Sell |
2,192,224
-52,975
| -2% | -$389K | ﹤0.01% | 2551 |
|
|
2017
Q1 | $16.7M | Buy |
2,245,199
+26,039
| +1% | +$194K | ﹤0.01% | 2515 |
|
|
2016
Q4 | $15.4M | Buy |
2,219,160
+73,801
| +3% | +$513K | ﹤0.01% | 2543 |
|
|
2016
Q3 | $17.7M | Buy |
2,145,359
+523,549
| +32% | +$4.31M | ﹤0.01% | 2420 |
|
|
2016
Q2 | $13.1M | Sell |
1,621,810
-4,136
| -0.3% | -$33.5K | ﹤0.01% | 2513 |
|
|
2016
Q1 | $8.26M | Buy |
1,625,946
+115,390
| +8% | +$586K | ﹤0.01% | 2714 |
|
|
2015
Q4 | $11.7M | Buy |
1,510,556
+79,600
| +6% | +$614K | ﹤0.01% | 2556 |
|
|
2015
Q3 | $8.24M | Buy |
1,430,956
+161,723
| +13% | +$931K | ﹤0.01% | 2702 |
|
|
2015
Q2 | $11.6M | Buy |
1,269,233
+995,477
| +364% | +$9.13M | ﹤0.01% | 2595 |
|
|
2015
Q1 | $3.32M | Buy |
+273,756
| New | +$3.32M | ﹤0.01% | 3194 |
|